Journal of Peking University(Health Sciences) ›› 2014, Vol. 46 ›› Issue (4): 578-581.

• Articles • Previous Articles     Next Articles

Chinese urologists’ practice patterns of diagnosing and treating chronic pelvic pain syndrome: a questionnaire survey

ZHANG Kai1, XU Ben1, XIAO Yun-xiang1△, SHANG Xue-jun2△, BAI Wen-jun3, WANG Xiao-feng3, LIU Ji-hong4, DENG Chun-hua5   

  1. (1. Department of Urology, Peking University First Hospital, Beijing 100034, China; 2. Department of Andrology, Nanjing General Hospital of Nanjing Military Command, Nanjing 210002, China; 3. Department of Urology, Peking University People’s Hospital, Beijing 100044, China; 4. Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 5. Department of Urology, First Hospital of Sun Yatsen University, Guangzhou 510080, China)
  • Online:2014-08-18 Published:2014-08-18

Abstract: Objective:To investigate the application of the Chinese Urological Association (CUA) guidelines on prostatitis and the effects on the clinical practice patterns of diagnosing and treating chronic pelvic pain syndrome (CPPS) among Chinese urologists. Methods: We conducted a questionnaire investigation of the CUA guidelines on prostatitis among the urologists from 399 hospitals in 63 cities of China, and performed statistical analyses on all the eligible questionnaires collected. Results: Of the 2 251 questionnaires distributed, 2 046 (90.9%) were eligible, of which 92.5% were from the urologists in tertiary or secondary hospitals, of whom 72.3% had senior or intermediate professional titles, and 90.2% had studied the CUA guidelines. Most respondents agreed that Type Ⅲ prostatitis was a clinical syndrome, of which the diagnosis should be made after other conditions with similar symptoms had been ruled out and the aim was to relieve pain, alleviate urination symptoms and improve quality of life. Those who had and those who had not studied the CUA guidelines differed in their viewpoints on CPPS as illustrated in the guidelines. In clinical practice, the most common treatment options for CPPS were pharmaceutical therapy (95.0%), life style adjustment (88.9%), and psychotherapy (79.9%), and the most frequently prescribed drugs were phytotherapy (84.5%), α-blockers (79.0%) and antibiotics (64.0%). Conclusion: CUA guidelines on prostatitis has gained a nationwide application and promoted the standardization of the management of CPPS in China.

Key words: Pelvic pain, Guidebooks, Diagnosis, Therapy, Questionnaires

[1] Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734.
[2] Wanyin HOU,Jie DONG. Acquired cystic kidney hemorrhage in peritoneal dialysis patients: A report of three cases [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 546-550.
[3] Shengjia PENG,Yu QI,Lijie SUN,Dan LI,Xinyu WANG,Jiangli HAN,Baoxia CHEN,Yuan ZHANG. Afferent baroreflex failure with hyponatremia: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 357-361.
[4] Chen CHEN,Yuhong LIANG. Root canal therapy of maxillary molars with atypical canals: A report of three cases [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 190-195.
[5] Han ZHANG,Yixuan QIN,Diyuan WEI,Jie HAN. A preliminary study on compliance of supportive treatment of patients with periodontitis after implant restoration therapy [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 39-44.
[6] Hai-hong YAO,Fan YANG,Su-mei TANG,Xia ZHANG,Jing HE,Yuan JIA. Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 966-974.
[7] Hai-hong JIANG,Xiao-fan LI,Jian-liu WANG. Relationship between chronic radiation enteritis of cervical cancer and gut microbiota [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 619-624.
[8] Yan XIONG,Xin LI,Li LIANG,Dong LI,Li-min YAN,Xue-ying LI,Ji-ting DI,Ting LI. Evaluation of accuracy of pathological diagnosis based on thyroid core needle biopsy [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 234-242.
[9] Yan XIONG,Bo ZHANG,Li-gong NIE,Shi-kai WU,Hu ZHAO,Dong LI,Ji-ting DI. Thoracic SMARCA4-deficient undifferentiated tumor-pathological diagnosis and combined immune checkpoint inhibitor treatment [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 351-356.
[10] Xue-mei HA,Yong-zheng YAO,Li-hua SUN,Chun-yang XIN,Yan XIONG. Solid placental transmogrification of the lung: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 357-361.
[11] Bo-han NING,Qing-xia ZHANG,Hui YANG,Ying DONG. Endometrioid adenocarcinoma with proliferated stromal cells, hyalinization and cord-like formations: A case report [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 366-369.
[12] Rui-jie CAO,Zhong-qiang YAO,Peng-qing JIAO,Li-gang CUI. Comparison of diagnostic efficacy of different classification criteria for Takayasu arteritis in Chinese patients [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1128-1133.
[13] Zi WANG,Jun-jun ZHANG,Li ZUO,Yue WANG,Wen-ge LI,Hong CHENG,Guang-yan CAI,Hua-ying PEI,Li-hua WANG,Xu-jie ZHOU,Su-fang SHI,Li-jun LIU,Ji-cheng LV,Hong ZHANG. Efficacy of plasma exchange in severe crescentic IgA nephropathy: A multicentered, cohort study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1038-1046.
[14] Jing LIU,Ai-dong LU,Ying-xi ZUO,Jun WU,Zhi-zhuo HUANG,Yue-ping JIA,Ming-ming DING,Le-ping ZHANG,Jiong QIN. Clinical characteristics and prognosis of seizures in 75 children with acute lymphoblastic leukemia [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 948-953.
[15] Sheng-jie LIU,Hui-min HOU,Zheng-tong LV,Xin DING,Lu WANG,Lei ZHANG,Ming LIU. Bipolar androgen therapy followed by immune checkpoint inhibitors in metastatic castration resistant prostate cancer: A report of 4 cases [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 766-769.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!